Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 129 | 1.88 |
09:54 ET | 21549 | 1.88 |
09:56 ET | 900 | 1.88 |
10:06 ET | 5000 | 1.8801 |
10:12 ET | 150 | 1.8874 |
10:32 ET | 834 | 1.88 |
10:33 ET | 100 | 1.888 |
11:08 ET | 300 | 1.87 |
11:26 ET | 200 | 1.8702 |
11:33 ET | 1900 | 1.83 |
11:47 ET | 200 | 1.8301 |
11:51 ET | 369 | 1.82 |
12:00 ET | 800 | 1.83 |
12:20 ET | 818 | 1.8234 |
12:21 ET | 328 | 1.8216 |
12:41 ET | 100 | 1.8219 |
12:43 ET | 100 | 1.82 |
12:56 ET | 600 | 1.82 |
12:57 ET | 175 | 1.82 |
12:59 ET | 5450 | 1.8 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 47.3M | -1.7x | --- |
Kezar Life Sciences Inc | 42.2M | -0.4x | --- |
Cue Biopharma Inc | 47.7M | -0.9x | --- |
BioLine RX Ltd | 47.3M | -0.7x | --- |
DURECT Corp | 39.7M | -1.5x | --- |
Atara Biotherapeutics Inc | 37.8M | -0.1x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.3M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.53 |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | 3.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.